Cel Sci Corporation (CVM)

[drkazmd65]

Read the post Foxwoods already made,... it could be very lucrative IF it plays out as the company anticipates.

It is actually quite hard to find a similar company with a similar potential treatment to compare what we might have to. One of the closest comparisons might be with Dendreon Pharma and the burst of shareprice (apparently overhyped at the time) about two years ago.

Shortly after their lead candidate drug was approved - their shareprice (based on presumbed profitability) shot up to over $30/share. It has since tailed back down to under $5/share.

Dendreon's share structure wasn't vastly different from what we have here - we have ~2x the number of trading/tradable shares as they do.

We might have a similar run-up upon approval - we might not. I would hope we have better staying power than they did. Their candidate still appears quite effective, but they have been having issues getting it approved for treatemtments because (among other things) their candidate drug is extremely expensive and has to be tailored to the cancer patient rather than being a one-for-all kind of drug.

Short version of the story - what Foxwoods writes could very well end up resembling our reality in that time scale.